• Unfinished Drug Substance

    FDA GFI-169: A form of the drug substance that is further processed to produce the form of the drug substance used to manufacture the drug product.

  • Unfinished Drug Substance Tests

    FDA GFI-169: Measures used to assess the quality attributes of an unfinished drug substance and/or its suitability for use in the manufacturing process.